Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | IDH1 | O75874 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PPOX | P50336 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5389865 | 0.87 | ALDH2 (0.43) | L3MBTL1LMNAKMT2AALDH2ALDH1A1 | |
| SCHEMBL5384644 | 0.87 | ALDH2 (0.43) | L3MBTL1LMNAKMT2AALDH2ALDH1A1 | |
| SCHEMBL5384650 | 0.87 | ALDH2 (0.43) | L3MBTL1LMNAKMT2AALDH2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL6231512 | 0.86 | ALDH2 (0.42) | L3MBTL1LMNAKMT2AALDH2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL6231515 | 0.86 | ALDH2 (0.42) | L3MBTL1LMNAKMT2AALDH2ALDH1A1 | |
| SCHEMBL25577858 | 0.84 | L3MBTL1 (0.54) | L3MBTL1LMNAKMT2AALDH2EPHX2 | |
| SCHEMBL5208842 | 0.84 | L3MBTL1 (0.54) | L3MBTL1LMNAKMT2AALDH2EPHX2 | |
| SCHEMBL25577860 | 0.84 | L3MBTL1 (0.54) | L3MBTL1LMNAKMT2AALDH2EPHX2 | |
| SCHEMBL5380952 | 0.84 | APP (0.37) | L3MBTL1LMNAKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL5381925 | 0.84 | APP (0.37) | L3MBTL1LMNAKMT2AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070161681-A1 | ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES | PFIZER INC. (US) | 2007-07-12 | — | — | US | disclosed |
| US-20070161681-A1 | ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES | PFIZER INC. (US) | 2007-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070161681-A1 | ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES | PDE4A, PDE4B, PDE4D | L3MBTL1 3318/4885LMNA 4413/4885KMT2A 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.